Current guidelines for high-density lipoprotein cholesterol in therapy and future directions

Many studies have suggested that a significant risk factor for atherosclerotic cardiovascular disease (ASCVD) is low high-density lipoprotein cholesterol (HDL-C). Therefore, increasing HDL-C with therapeutic agents has been considered an attractive strategy. In the prestatin era, fibrates and niacin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Subedi, Bishnu H, Joshi, Parag H, Jones, Steven R, Martin, Seth S, Blaha, Michael J, Michos, Erin D
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2014
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986285/
https://ncbi.nlm.nih.gov/pubmed/24748800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S45648
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars